Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus

Chun‐Ping Chang(Chung Yuan Christian University), Ya‐Hui Chi(National Health Research Institutes)
Molecular Cancer Therapeutics
April 9, 2024
Cited by 9


Related Papers